Skip to main content

Closed

SILO: Silo Pharma, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin-6631.2%

ROIC-75.7%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-123.8×

Current ratio9.65×

Silo Pharma, Inc.

SILONASDAQ Capital Market·USD·Closed

Silo Pharma, Inc.

SILONASDAQ·USD·Closed

$4.19

−1.41%

$4.19

−$0.06 (1.41%)

52W Range

7thpctl

Volume

0.02×avg

Mkt Cap

4.73MUSD

P/E

-0.6TTM

Div Yield

–ann

52W Range

7thpctl

Volume

0.02×avg

Market Cap

4.73MUSD

P/E Ratio

-0.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings